BDBM476476 (2S)-[(4S,5S)-5-(4-cyanophenyl)-4- methyl-4,5-dihydro-1,3-oxazol-2-yl]- 1-[N2-cyclohexyl-N6-(methylsulfonyl)- D-lysyl]-N-(thiophen-2- ylmethyl)piperazine-2-carboxamide::US10875851, Example 132

SMILES C[C@@H]1N=C(N2CCN(C(=O)[C@@H](CCCCNS(C)(=O)=O)NC3CCCCC3)[C@H](C(=O)NCc3cccs3)C2)O[C@H]1c1ccc(C#N)cc1

InChI Key InChIKey=ABCHEZNYPFCFNO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476476   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 476476BDBM476476((2S)-[(4S,5S)-5-(4-cyanophenyl)-4- methyl-4,5-dihy...)
Affinity DataIC50: 52.6nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent